News
BCPC
162.32
+2.29%
3.63
Weekly Report: what happened at BCPC last week (0601-0605)?
Weekly Report · 2d ago
Weekly Report: what happened at BCPC last week (0525-0529)?
Weekly Report · 06/01 10:27
Balchem to participate in Wells Fargo Industrials Conference
PUBT · 05/27 11:02
Balchem (BCPC) Valuation Check After Mixed Momentum And Perceived 15.3% Undervaluation
Simply Wall St · 05/25 14:13
Weekly Report: what happened at BCPC last week (0518-0522)?
Weekly Report · 05/25 10:30
My Top Dividend Growth Picks In Each GICS Sector
Seeking Alpha · 05/19 14:21
Weekly Report: what happened at BCPC last week (0511-0515)?
Weekly Report · 05/18 10:30
What Balchem (BCPC)'s Q1 2026 Earnings Growth and Buybacks Mean For Shareholders
Simply Wall St · 05/16 12:43
Balchem (BCPC) Valuation Check After Q1 Earnings Beat And Ongoing Share Buybacks
Simply Wall St · 05/12 06:37
Weekly Report: what happened at BCPC last week (0504-0508)?
Weekly Report · 05/11 10:27
Balchem study finds OptiMSM supports knee comfort, quality of life in adults
PUBT · 05/08 18:05
Balchem (BCPC) Is Down 6.9% After Strong Q1 Earnings And Buyback Completion - What's Changed
Simply Wall St · 05/07 01:51
Assessing Balchem (BCPC) Valuation As Mixed Price Momentum Meets Conflicting Fair Value Estimates
Simply Wall St · 05/05 00:36
Most and least shorted materials stocks over $2B market cap, featuring MP Materials
Seeking Alpha · 05/04 19:45
Analysts Offer Insights on Materials Companies: LyondellBasell (LYB), Balchem (BCPC) and Agnico Eagle (AEM)
TipRanks · 05/04 12:21
Balchem Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/04 11:19
Balchem Price Target Raised to $5.16/Share From $5.10 by HC Wainwright & Co.
Dow Jones · 05/04 11:19
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $5.16
Benzinga · 05/04 11:09
Balchem: Buy Rating Reiterated as Earnings Outlook Improves and $190 Price Target Is Maintained
TipRanks · 05/04 10:35
Weekly Report: what happened at BCPC last week (0427-0501)?
Weekly Report · 05/04 10:24
More
Webull provides a variety of real-time BCPC stock news. You can receive the latest news about Balchem Corp through multiple platforms. This information may help you make smarter investment decisions.
About BCPC
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.